BAJAJ BROKING

Notification close image
No new Notification messages
card image
Cash UR Drive Marketing IPO is Open!
Apply for the Cash UR Drive Marketing IPO through UPI in just minutes.
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

29452

544350

AGARWALEYE

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

DR AGARWALS HEALTH CARE L performance

Today’s low

Today’s high

₹ 450.10 ₹ 459.00
₹ 451.85

52 week low

52 week high

₹ 327.00 ₹ 494.50
₹ 451.85

Open Price

₹ 459.00

Prev. Close

₹ 456.85

Volume (Shares)

69960.00

Total traded value

₹ 316.11

Upper Circuit

₹ 548.20

Lower Circuit

₹ 365.50

info

DR AGARWALS HEALTH CARE L Share Price Update

As of the latest trading session, DR AGARWALS HEALTH CARE L share price is currently at ₹ 451.85, which is down by ₹ -5.00 from its previous closing. Today, the stock has fluctuated between ₹ 450.10 and ₹ 459.00. Over the past year, DR AGARWALS HEALTH CARE L has achieved a return of 0.00 %. In the last month alone, the return has been 11.78 %. Read More...

Investment Returns

Over 1 Month 11.78% Over 3 Months 27.78% Over 6 Months 12.49% Over 1 Year 0.00%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

DR AGARWALS HEALTH CARE L fundamentals


  • Market cap (Cr)

    14,285.60

  • P/E Ratio (TTM)

    654.71

  • Beta

    0.54

  • Book Value / share

    61.16

  • Return on equity

    1.44%

  • EPS (TTM)

    0.95

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    26.61

info icon alternate text
  • Market cap (Cr)

    14,282.50

  • P/E Ratio (TTM)

    654.71

  • Beta

    0.54

  • Book Value / share

    61.16

  • Return on equity

    1.44%

  • EPS (TTM)

    0.95

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    26.61

info icon alternate text

DR AGARWALS HEALTH CARE L Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars MAR 2025 (Values in Cr)
Revenue 281.02
Operating Expense 270.69
Net Profit 26.61
Net Profit Margin (%) 9.46
Earnings Per Share (EPS) 0.85
EBITDA 97.15
Effective Tax Rate (%) 21.85
Particulars DEC 2024 (Values in Cr)
Revenue 267.93
Operating Expense 265.60
Net Profit 7.62
Net Profit Margin (%) 2.84
Earnings Per Share (EPS) 0.25
EBITDA 74.47
Effective Tax Rate (%) 37.02
Particulars SEP 2024 (Values in Cr)
Revenue 255.34
Operating Expense 259.43
Net Profit -3.68
Net Profit Margin (%) -1.44
Earnings Per Share (EPS) -0.13
EBITDA 62.42
Effective Tax Rate (%) 745.61
Particulars JUN 2024 (Values in Cr)
Revenue 239.60
Operating Expense 0.00
Net Profit -8.62
Net Profit Margin (%) -3.59
Earnings Per Share (EPS) 0.00
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 224.78
Operating Expense 214.51
Net Profit 16.68
Net Profit Margin (%) 7.42
Earnings Per Share (EPS) 0.60
EBITDA 80.78
Effective Tax Rate (%) 29.29
Particulars MAR 2025 (Values in Cr)
Revenue 1043.89
Operating Expense 1045.10
Net Profit 21.93
Net Profit Margin (%) 2.10
Earnings Per Share (EPS) 0.74
EBITDA 284.90
Effective Tax Rate (%) 43.18
Particulars MAR 2024 (Values in Cr)
Revenue 835.06
Operating Expense 828.39
Net Profit 23.83
Net Profit Margin (%) 2.85
Earnings Per Share (EPS) 25.55
EBITDA 259.09
Effective Tax Rate (%) 46.64
Particulars MAR 2023 (Values in Cr)
Revenue 597.64
Operating Expense 591.98
Net Profit 31.59
Net Profit Margin (%) 5.28
Earnings Per Share (EPS) 39.83
EBITDA 147.78
Effective Tax Rate (%) 640.92
Particulars MAR 2022 (Values in Cr)
Revenue 361.59
Operating Expense 372.90
Net Profit -1.47
Net Profit Margin (%) -0.40
Earnings Per Share (EPS) -2.15
EBITDA 94.91
Effective Tax Rate (%) -54.73
Particulars MAR 2021 (Values in Cr)
Revenue 232.24
Operating Expense 288.08
Net Profit -54.08
Net Profit Margin (%) -23.28
Earnings Per Share (EPS) -78.83
EBITDA 35.44
Effective Tax Rate (%) -3.64
Particulars MAR 2024 (Values in Cr)
Book Value / Share 1435.71
ROE % 7.45
ROCE % 10.39
Total Debt to Total Equity 0.93
EBITDA Margin 29.02
Particulars MAR 2023 (Values in Cr)
Book Value / Share 794.29
ROE % 18.14
ROCE % 11.67
Total Debt to Total Equity 1.77
EBITDA Margin 28.33
Particulars MAR 2022 (Values in Cr)
Book Value / Share 309.59
ROE % 14.67
ROCE % 12.50
Total Debt to Total Equity 2.06
EBITDA Margin 29.22
Particulars MAR 2021 (Values in Cr)
Book Value / Share 268.57
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.80
EBITDA Margin 19.20
Particulars MAR 2020 (Values in Cr)
Book Value / Share 363.01
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.65
EBITDA Margin 25.71
Particulars MAR 2024 (Values in Cr)
Book Value / Share 1315.31
ROE % 1.44
ROCE % 6.43
Total Debt to Total Equity 0.70
EBITDA Margin 29.52
Particulars MAR 2023 (Values in Cr)
Book Value / Share 708.15
ROE % 11.95
ROCE % 8.10
Total Debt to Total Equity 1.11
EBITDA Margin 29.24
Particulars MAR 2022 (Values in Cr)
Book Value / Share 289.96
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 1.03
EBITDA Margin 26.69
Particulars MAR 2021 (Values in Cr)
Book Value / Share 293.27
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.66
EBITDA Margin 15.76
Particulars MAR 2020 (Values in Cr)
Book Value / Share 371.10
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.50
EBITDA Margin 22.12
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 124.86
Total Assets 2752.81
Total Liabilities 2752.81
Total Equity 1379.51
Share Outstanding 9329292
Price to Book Ratio 0.00
Return on Assets (%) 3.01
Return on Capital (%) 4.7
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 148.53
Total Assets 1825.17
Total Liabilities 1825.17
Total Equity 659.07
Share Outstanding 7926103
Price to Book Ratio 0.00
Return on Assets (%) 5.15
Return on Capital (%) 9.27
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 116.68
Total Assets 1026.13
Total Liabilities 1026.13
Total Equity 233.82
Share Outstanding 6859969
Price to Book Ratio 0.00
Return on Assets (%) 3.67
Return on Capital (%) 7.19
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 64.94
Total Assets 786.98
Total Liabilities 786.98
Total Equity 198.69
Share Outstanding 6859969
Price to Book Ratio 0.00
Return on Assets (%) -7.04
Return on Capital (%) -14.54
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 63.37
Total Assets 2186.94
Total Liabilities 2186.94
Total Equity 1227.21
Share Outstanding 9329292
Price to Book Ratio 0.00
Return on Assets (%) 1.08
Return on Capital (%) 1.53
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 97.48
Total Assets 1387.58
Total Liabilities 1387.58
Total Equity 561.56
Share Outstanding 7926103
Price to Book Ratio 0.00
Return on Assets (%) 2.27
Return on Capital (%) 3.64
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 60.00
Total Assets 692.45
Total Liabilities 692.45
Total Equity 198.91
Share Outstanding 6859969
Price to Book Ratio 0.00
Return on Assets (%) -0.21
Return on Capital (%) -0.33
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 32.77
Total Assets 643.38
Total Liabilities 643.38
Total Equity 201.18
Share Outstanding 6859969
Price to Book Ratio 0.00
Return on Assets (%) -8.40
Return on Capital (%) -14.94
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 29.13
Total Assets 596.25
Total Liabilities 596.25
Total Equity 254.57
Share Outstanding 6859969
Price to Book Ratio 0.00
Return on Assets (%) -5.98
Return on Capital (%) -8.99
Particulars MAR 2024 (Values in Cr)
Net Income 140.56
Cash from Operations 378.05
Cash from Investing -913.86
Cash from Financing 552.67
Net change in Cash -15.23
Free Cash Flow 610.36
Particulars MAR 2023 (Values in Cr)
Net Income 83.59
Cash from Operations 268.48
Cash from Investing -509.08
Cash from Financing 303.33
Net change in Cash 27.36
Free Cash Flow 426.29
Particulars MAR 2022 (Values in Cr)
Net Income 56.76
Cash from Operations 179.92
Cash from Investing -155.35
Cash from Financing 35.43
Net change in Cash 44.41
Free Cash Flow 250.51
Particulars MAR 2021 (Values in Cr)
Net Income -48.35
Cash from Operations 106.65
Cash from Investing -36.56
Cash from Financing -37.10
Net change in Cash 16.55
Free Cash Flow 233.20
Particulars MAR 2020 (Values in Cr)
Net Income -10.80
Cash from Operations 119.58
Cash from Investing -79.74
Cash from Financing -73.49
Net change in Cash -55.58
Free Cash Flow 321.09
Particulars MAR 2024 (Values in Cr)
Net Income 44.66
Cash from Operations 234.55
Cash from Investing -817.60
Cash from Financing 570.41
Net change in Cash -25.61
Free Cash Flow 368.61
Particulars MAR 2023 (Values in Cr)
Net Income -5.84
Cash from Operations 164.97
Cash from Investing -435.57
Cash from Financing 315.94
Net change in Cash 33.06
Free Cash Flow 241.43
Particulars MAR 2022 (Values in Cr)
Net Income -0.95
Cash from Operations 86.20
Cash from Investing -98.43
Cash from Financing 40.16
Net change in Cash 20.03
Free Cash Flow 164.48
Particulars MAR 2021 (Values in Cr)
Net Income -52.18
Cash from Operations 51.20
Cash from Investing -26.44
Cash from Financing -21.11
Net change in Cash -1.27
Free Cash Flow 74.42
Particulars MAR 2020 (Values in Cr)
Net Income -35.66
Cash from Operations 43.24
Cash from Investing -36.78
Cash from Financing -59.80
Net change in Cash -56.18
Free Cash Flow 175.09
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7344.10 73.03 12.87 105596.89 6002.15 / 7634.45
FORTIS MALAR HOSPITALS LIMITED 69.94 333.05 4.34 131.08 51.01 / 98.70
SHREE PACETRONIX LTD. 75.65 36.37 1.97 27.23 61.11 / 221.50
TRANSGENE BIOTEK LTD. 4.60 0.00 3.47 34.85 3.22 / 9.75
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7344.10 81.46 12.09 105596.89 6002.15 / 7634.45
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 33.00 0.00 -13.04 24.65 28.34 / 59.90
KOVAI MEDICAL CENTER & HOSPITA 6260.65 32.68 6.30 6849.15 4279.45 / 6515.00

DR AGARWALS HEALTH CARE L Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
451.85 -1.09 redarrow
red-green-graph indicator
2 Bearish
14 Bullish
  • 5 Days 452.50
  • 26 Days 434.20
  • 10 Days 449.10
  • 50 Days 419.60
  • 12 Days 447.40
  • 100 Days 413.40
  • 20 Days 439.70
  • 200 Days 405.80
456.62 PIVOT

First Support

446.83

First Resistance

466.63

Second Support

436.82

Second Resistance

476.42

Third Support

427.03

Third Resistance

486.43

RSI

64.06

ADX

50.52

MACD

13.15

Williams % R

-63.28

Commodity Channel Index (CCI)

81.68

Date

2025-08-01

Week

119380.00

Same Day

39956.00

Month

174853.00

1 Year

0.54

3 Year

0.53

Over 1 Month

11.78%

down

Over 1 Year

0.00%

down

Over 3 Months

27.78%

down

Over 3 Years

0.00%

down

Over 6 Months

12.49%

down

Over 5 Years

0.00%

down

DR AGARWALS HEALTH CARE L shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
1.87%
Promoter Holdings
32.42%
FII
59.26%
DII
6.43%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Hyperion Investments Pte. Ltd 7.3193988E7 (23.15%) Public Shareholding
Claymore Investments (mauritius) Pte. Ltd 3.22963E7 (10.22%) Public Shareholding
Arvon Investments Pte. Ltd. 3.127547E7 (9.89%) Public Shareholding
Government Of Singapore 2.0485625E7 (6.48%) Public Shareholding
Anosh Agarwal 1.8458922E7 (5.84%) Shareholding of Promoter and Promoter Group
Athiya Agarwal 1.643907E7 (5.2%) Shareholding of Promoter and Promoter Group
Amar Agarwal 1.5648321E7 (4.95%) Shareholding of Promoter and Promoter Group
Ashvin Agarwal 1.5044121E7 (4.76%) Shareholding of Promoter and Promoter Group
Adil Agarwal 1.4559452E7 (4.61%) Shareholding of Promoter and Promoter Group
Adil Agarwal, Anosh Agarwal, Ashvin Agarwal 1.3540361E7 (4.28%) Shareholding of Promoter and Promoter Group
Polar Capital Funds Plc - Healthcare Opportunities 7736753.0 (2.45%) Public Shareholding
Motilal Oswal Small Cap Fund 5806393.0 (1.84%) Public Shareholding
Dr. Agarwal's Eye Institute Private Limited 4342320.0 (1.37%) Shareholding of Promoter and Promoter Group
Invesco India Midcap Fund 4305673.0 (1.36%) Public Shareholding
Monetary Authority Of Singapore 3202207.0 (1.01%) Public Shareholding
Ashar Agarwal 2983801.0 (0.94%) Shareholding of Promoter and Promoter Group
A Urmila 743785.0 (0.24%) Shareholding of Promoter and Promoter Group
Farah Agarwal 743815.0 (0.24%) Shareholding of Promoter and Promoter Group
Centaur Healthtech Llc - Usa 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Printrack 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Maya Furniture Private Limited 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Grf Bio Private Limited 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Fab Infinity Consultancy (opc) Private Limited 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Orbit International 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Chestnut Storeys Private Limited 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Centaur Billing Private Limited 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Maatrum Technologies And Legal Ventures Private Limited 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Linendots Design Consultants Private Limited 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Elisar Life Sciences Private Limited 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Ace Associates 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Anosh Agarwal Holding On Behalf Of Dr. Amar Agarwal Family Trust 30.0 (0.0%) Shareholding of Promoter and Promoter Group
Anosh Agarwal Holding On Behalf Of Dr. Anosh Agarwal Family Trust 30.0 (0.0%) Shareholding of Promoter and Promoter Group
Anosh Agarwal Holding On Behalf Of Dr. Ashvin Agarwal Family Trust 30.0 (0.0%) Shareholding of Promoter and Promoter Group
Anosh Agarwal Holding On Behalf Of Dr. Ashar Agarwal Family Trust 30.0 (0.0%) Shareholding of Promoter and Promoter Group
Anosh Agarwal Holding On Behalf Of Dr. Adil Agarwal Family Trust 30.0 (0.0%) Shareholding of Promoter and Promoter Group
Aira Agarwal 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Aneira Agarwal 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Azai Agarwal 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Arick Agarwal 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Ananya Seth Agarwal 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Amaarah Agarwal 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Agastya Agarwal 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Ashvin Agarwal Huf 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Pankaj Sondhi 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Sunitha Rana Agarwal 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Ayesha Fazilath Fiaz 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Shakira Ahmed 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Fiaz Ahmed 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Rajesh Kumar Kakkar 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Geeta Kakkar 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Aanchal Kakkar 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Sahiba Sadiq 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Maqsood Ahmed 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Kouser Basheer 0.0 (0.0%) Shareholding of Promoter and Promoter Group
P G Thomas 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Neena Thomas 0.0 (0.0%) Shareholding of Promoter and Promoter Group
George Pt 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Fouzia Khan 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Muktha Seth 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Kamalesh Kumar Seth 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Tejeshwar Seth 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Kaamna Kakkar 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Rambha Seth 0.0 (0.0%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

DR AGARWALS HEALTH CARE L corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

DR AGARWALS HEALTH CARE L Share Price

Dr Agarwal's Health Care Limited was incorporated as Dr. Agarwal's Health Care Limited' pursuant to Certificate of Incorporation dated April 19, 2010, issued by the Registrar of Companies, Tamil Nadu at Chennai and commenced operations pursuant to Certificate for Commencement of Business dated May 29, 2010, issued by the RoC.

The Company provide eye care services and products, covering cataract surgeries, refractive treatments and other surgeries; and services such as consultations, clinical investigations and diagnoses and non-surgical treatments; and sell opticals, contact lenses and accessories, and eye care related pharmaceutical products. It offer surgeries for multiple eye ailments, including cataract, corneal, retinal, and refractive, and other surgeries. It provide other treatments, including glaucoma treatments, squint treatments, and oculoplasty surgeries, among others. Some of the key surgical capabilities include intraocular lens procedures, cornea transplantation, pinhole pupilloplasty, single pass four-throw pupilloplasty and LASIK surgeries.

The Company had set up eye clinics by entering into Telangana and Karnataka markets during the year 2010. In 2012, it entered the Africa market with Dr, Amelia Buque to jointly promote eye hospitals and other health care related services in Mozambique. In addition to operations in India, the Company commenced international operations in 2012, which presently operate 15 Facilities in Africa, where it provide a range of eye care services, including treatments for cataract, glaucoma, diabetic retinopathy, retinal detachment, and dry eye, along with refractive surgeries, and paediatric and neuro ophthalmological.

Further, the Company acquired hospitals in Maharashtra in 2017. It launched the 100th eye care facility in 2021; further it strengthened the Gujarat market by acquiring the eye care business in 2022; acquired Punjab Eye Hospital in 2023; acquired an eye care business in Varanasi, Uttar Pradesh and acquired Dr Thind Eye Care Private Limited in Punjab in 2024.

The Company is planning an IPO by raising funds through Fresh Issue Equity Shares of Rs 300 Crore and by issuing upto 69,568,204 Equity Shares through Offer for Sale.

Parent organization Indian Private
NSE symbol AGARWALEYE
Founded 2010
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Dr Agarwals Health Care Ltd?

Answer Field

Dr Agarwals Health Care Ltd share price is for NSE ₹ 451.85 & for BSE ₹ 451.00 as on Aug 01 2025 03:30 PM.

What is the Market Cap of Dr Agarwals Health Care Ltd Share?

Answer Field

The market cap of Dr Agarwals Health Care Ltd for NSE ₹ 421.54 & for BSE ₹ 420.75 as on Aug 01 2025 03:30 PM.

What is the 52 Week High and Low of Dr Agarwals Health Care Ltd?

Answer Field

The 52 Week High and Low of Dr Agarwals Health Care Ltd for NSE is ₹ 494.50 and ₹ 327.00 and for BSE is ₹ 493.35 and ₹ 327.40.

What is 1 year return for Dr Agarwals Health Care Ltd?

Answer Field

The 1 year returns on the stock has been 0.00%.

What is the P/E Ratio of Dr Agarwals Health Care Ltd Share?

Answer Field

As on Aug 01 2025 03:30 PM the price-to-earnings (PE) ratio for Dr Agarwals Health Care Ltd share is 654.71.

What is the PB ratio of Dr Agarwals Health Care Ltd Share?

Answer Field

As on Aug 01 2025 03:30 PM, the price-to-book (PB) ratio for Dr Agarwals Health Care Ltd share is 61.16.

How to Buy Dr Agarwals Health Care Ltd Share?

Answer Field

You can trade in Dr Agarwals Health Care Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Dr Agarwals Health Care Ltd Share on Bajaj Broking App?

Answer Field

To buy Dr Agarwals Health Care Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Dr Agarwals Health Care Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|